Major Histocompatibility Complex Binding Analysis
Major Histocompatibility Complex Binding Analysis is a computational and experimental methodology used in immunology to predict and evaluate the affinity of peptide antigens for binding to major histocompatibility complex molecules, thereby assessing their potential to elicit T-cell immune responses.
25
Publications
4.5K
Citations
100
Authors
47
Institutions
Publications per year
2017–2026
1
Variants
Mhc Binding Analysis
Parents
25
ProPred: prediction of HLA-DR binding sites
Harpreet Singh, Gajendra P. S. Raghava · Bioinformatics · 2001 · 852 citations · Full text
1–5 of 25
100
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 100
47
National Cancer Institute
Bethesda, United States
2 h-index
8 publications
1.3K citations
Cytel (United States)
Cambridge, United States
2 h-index
10 publications
3K citations
Technical University of Denmark
Kongens Lyngby, Denmark
2 h-index
12 publications
2.2K citations
Jenner Institute
Oxford, United Kingdom
2 h-index
7 publications
665 citations
Institute of Microbial Technology
Chandigarh, India
2 h-index
4 publications
1.9K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
5 publications
1.7K citations
Arizona State University
Tempe, United States
1 h-index
1 publications
43 citations
University of Illinois Chicago
Chicago, United States
1 h-index
2 publications
106 citations
1–8 of 47
4 publications · 1.3K citations
4
h-index
JI · 3 publications · 1.5K citations
3
h-index
2 publications · 330 citations
2
h-index
2 publications · 96 citations
2
h-index
Repository · 1 publications · 18 citations
1
h-index
1–5